Evaluation of HEArt invoLvement in Patients With FABRY Disease
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorWuerzburg University Hospital
About this trial
This study evaluates predictors for the incidence of arrhythmias and sudden cardiac death as well as terminal heart failure in patients with Fabry disease.
Eligibility criteria
Qualifiers
Fabry disease (genetically confirmed)
Signed informed consent
18 years and older
Disqualifiers
No informed consent
Withdrawal of informed consent
Trial design
Treatments tested in this trial
- Not listed
Trial groups
No trial groups listed
Sponsors and collaborators
Wuerzburg University Hospital
Lead sponsor
Competence Network Heart Failure
Collaborator
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Collaborator
St George's, University of London
Collaborator
Source ClinicalTrials.gov